UB Paderborn / Katalog / Suche / in CDI

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2021-02, Vol.19 (1), p.46-52

2021

Link zum Volltext

Verfügbarkeit prüfen

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.25-26

2016

Link zum Volltext

Verfügbarkeit prüfen

PS87. An update on prediction of treatment outcome in treatment resistant depression

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.30-30

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.70-70

2013

Link zum Volltext

Verfügbarkeit prüfen

Switching antidepressants in patients with treatment-resistant depression

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs

The clinical perspective on late-onset depression in European real-world treatment settings

W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE

PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH

Differential efficacy of escitalopram and nortriptyline ondimensional measures of depression

W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY

CYP2D6 Revisited in GENDEP: Inter-Platform Concordance

WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

SU85 - WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA

F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram

F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION

SA84 - PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

F128TRANSDIAGNOSTIC EFFECT ON PSYCHOPATHOLOGY BY PSYCHOSES GENES VARIANTS

SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES

Possible Modulatory Role of ARC Gene Variants in Mood Disorders

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

PS87. An update on prediction of treatment outcome in treatment resistant depression

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STARD studies: rare variant analysis and high-density imputation

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis: e1001326

Switching antidepressants in patients with treatment-resistant depression

Aktive Filter

Suchergebnisse filtern